Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Cocrystal Pharma Inc (COCP)

26 + Investors. Track Smart Money conviction in COCP. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +1
Streak
1Q ▲
Buyers last Q
45%

Smart Money Signals — COCP

Based on 26 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added COCP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
26 hedge funds hold COCP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +24% more funds vs a year ago

fund count last 6Q
+5 new funds entered over the past year (+24% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟠

More sellers than buyers — 45% buying

10 buying12 selling
Last quarter: 12 funds reduced or exited vs 10 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~7 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 4 → 6 → 4 → 7. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

42% of holders stayed for 2+ years

■ 42% conviction (2yr+) ■ 19% medium ■ 38% new
11 out of 26 hedge funds have held COCP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~7 new funds/quarter

1 → 4 → 6 → 4 → 7 new funds/Q
New funds entering each quarter: 4 → 6 → 4 → 7. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 46% veterans vs 35% newcomers

■ 46% veterans ■ 19% 1-2yr ■ 35% new
Entry-cohort mix of 26 holders: 12 (46%) are 2+ year veterans, 5 entered 1–2 years ago, and 9 (35%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
12 of 26 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in COCP. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.5
out of 10
Moderate Exit Risk
Exit risk score 4.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — COCP

In 2026 Q2, 10 hedge funds were net buyers of COCP (7 opened a new position, 3 added to an existing one), while 12 reduced or exited (6 trimmed, 6 sold completely) — a 45% buyer ratio, indicating roughly balanced activity. 40% of total institutional value in COCP is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +1 funds (more new holders than closures). Total institutional holders: 26.

Hedge Fund Ownership: COCP

How many hedge funds hold COCP — quarterly history vs. share price
Quarterly hedge fund ownership of COCP vs. share price

Market Analysis: COCP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: COCP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Cocrystal Pharma Inc (COCP) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much COCP has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 63d ago
COCP
+10.5%
XLV
+20.4%

COCP outperformed XLV by -9.9% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 18d ago
COCP
+3.6%
XLV
+12.5%

Since the filing became public, COCP outperformed XLV by -8.9% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

4 top-rated funds 0 high-conviction
Consensus
3.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: COCP
26 + Investors

Track Smart Money conviction in COCP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 26 25 4.0%
13F Shares 1M 776K 43.28%
Total Value $1M $771K 51.46%
New Positions 7 4 +3
Increased Positions 3 6 -3
Closed Positions 6 5 +1
Reduced Positions 6 5 +1
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: COCP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

26 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in COCP. Verified SEC 13F-HR filings.

QUARTER:
Top 23 COCP holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Ground Swell Capital, LLC 0.01% 10,752 $11K
2 XTX Topco Ltd 0.00% 29,342 $31K
3 Renaissance Technologies LLC 0.00% 179,628 $189K
4 Parallel Advisors, LLC 0.00% 12,569 $13K
5 Two Sigma Investments, LP 0.00% 175,379 $184K
6 Clean Yield Group 0.00% 418 —
7 Tower Research Capital LLC (TRC) 0.00% 3,984 $4K
8 Hrt Financial LP 0.00% 20,336 $21K
9 Neuberger Berman Group LLC 0.00% 31,886 $33K
10 Allied Private Wealth LLC 0.00% 32 —
11 Nvwm, LLC 0.00% 84 —
12 Vima LLC 0.00% 17 —
13 Vanguard Capital Management LLC 0.00% 358,228 $376K
14 Vanguard Fiduciary Trust Co 0.00% 24,016 $25K
15 Citadel Advisors LLC 0.00% 45,118 $47K
16 Jane Street Group, LLC 0.00% 25,761 $27K
17 BlackRock, Inc. 0.00% 73,746 $77K
18 Wells Fargo & Company/Mn 0.00% 6,257 $7K
19 SBI Securities Co., Ltd. 0.00% 33 —
20 UBS Group AG 0.00% 4,133 $4K
21 Northwestern Mutual Wealth Management Co 0.00% 817 —
22 Morgan Stanley 0.00% 871 —
23 Barclays plc 0.00% 42 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Cocrystal Pharma Inc (COCP)

What does the Smart Money Trend signal show for COCP?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added COCP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for COCP?

More sellers than buyers — 45% buying: Last quarter: 12 funds reduced or exited vs 10 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for COCP holders?

Elite ownership — 40% AUM from top-100 funds: 12 of 26 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in COCP. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held COCP?

42% of holders stayed for 2+ years: 11 out of 26 hedge funds have held COCP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Cocrystal Pharma Inc (COCP) following the 2026 Q2 hedge fund 13F filings?

As of today, COCP has moved +3.6% since the 2026 Q2 13F filing date (August 14, 2026), compared to +12.5% for the XLV sector ETF — an outperformance of -8.9%. Since the quarter end (June 30, 2026), COCP has gained +10.5% vs +20.4% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →